Odyssey Therapeutics, Inc. (ODTX)
Odyssey Therapeutics will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet
Odyssey Therapeutics Revenue
Odyssey Therapeutics had revenue of $3.00M in the twelve months ending September 30, 2024. In the year 2023, Odyssey Therapeutics had annual revenue of $1.04M.
Revenue (ttm)
$3.00M
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
$19,894
Employees
151
Market Cap
n/a
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 1.04M | - | - |
| Dec 31, 2022 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionODTX News
- 3 days ago - Odyssey Therapeutics Begins IPO Rollout - Seeking Alpha
- 7 days ago - Autoimmune biotech Odyssey Therapeutics files for a $100 million IPO - Renaissance Capital
- 7 days ago - Odyssey Therapeutics IPO Registration Document (S-1) - SEC